- Latest week
- 17 Jul 2026
- Close
- 210.680000
- Fair value
- 158.004312
- Next-week expectancy
- Positive 55.56%
DGX Chart Pack
Quest Diagnostics Incorporated
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, DGX rose 9.35%, moving from 192.67 to 210.68. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 2.61 and has improved across the 12-week window. Market Dynamics is 0.83 on the latest week. Next-week expectancy is positive at 55.56% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 210.68
- 12-Week Change
- 9.35%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 55.56%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 2.61
- Market Dynamics
- 0.83
Weekly Price
Price Action
Smart Money
Market Dynamics
Earnings vs Price
Earnings vs Price
Weekly price against rolling TTM EPS, both indexed to 100 from the first visible week.
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 210.68
- 12-Week Change
- 9.35%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 55.56%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 2.61
- Market Dynamics
- 0.83
Over the latest 12 completed weeks ending 2026-07-17, DGX rose 9.35%, moving from 192.67 to 210.68. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 2.61 and has improved across the 12-week window. Market Dynamics is 0.83 on the latest week. Next-week expectancy is positive at 55.56% based on similar historical setup states.
Industry Peers
United States equities in Diagnostics & Research
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| CDNA CareDx Inc | NASDAQ | 17 Jul 2026 | 27.95 | 40.47 | 27.68 | 39.73 | 42.15% |
| XWEL XWELL Inc. | NASDAQ | 17 Jul 2026 | 0.95 | 1.11 | 0.89 | 1.07 | 12.63% |
| PSNL Personalis Inc | NASDAQ | 17 Jul 2026 | 13.83 | 16.39 | 13.52 | 15.39 | 11.28% |
| ADPT Adaptive Biotechnologies Corp | NASDAQ | 17 Jul 2026 | 20.76 | 23.15 | 20.46 | 22.92 | 10.40% |
| MYGN Myriad Genetics Inc | NASDAQ | 17 Jul 2026 | 5.82 | 6.43 | 5.67 | 6.18 | 6.19% |
| VCYT Veracyte Inc | NASDAQ | 17 Jul 2026 | 55.93 | 60.82 | 55.62 | 59.13 | 5.72% |
| NEO NeoGenomics Inc | NASDAQ | 17 Jul 2026 | 13.98 | 15.04 | 13.80 | 14.61 | 4.54% |
| BLLN BillionToOne, Inc. Class A Common Stock | NASDAQ | 17 Jul 2026 | 125.12 | 131.64 | 119.47 | 130.31 | 4.15% |
| GRAL GRAIL, LLC | NASDAQ | 17 Jul 2026 | 69.98 | 75.16 | 69.45 | 72.62 | 3.77% |
| TWST Twist Bioscience Corp | NASDAQ | 17 Jul 2026 | 90.49 | 94.69 | 85.02 | 93.85 | 3.71% |
| DHR Danaher Corporation | NYSE | 17 Jul 2026 | 198.70 | 206.59 | 197.37 | 203.83 | 2.58% |
| ICLR ICON PLC | NASDAQ | 17 Jul 2026 | 165.75 | 173.23 | 162.83 | 170.00 | 2.56% |
| LH Laboratory Corporation of America Holdings | NYSE | 17 Jul 2026 | 277.20 | 290.65 | 262.11 | 283.36 | 2.22% |
| CSTL Castle Biosciences Inc | NASDAQ | 17 Jul 2026 | 23.67 | 25.13 | 22.46 | 24.16 | 2.07% |
| MTD Mettler-Toledo International Inc | NYSE | 17 Jul 2026 | 1288.16 | 1341.12 | 1279.06 | 1310.02 | 1.70% |
| NTRA Natera Inc | NASDAQ | 17 Jul 2026 | 266.88 | 282.00 | 261.63 | 271.39 | 1.69% |